We are live on ! Find out more
DCMM

DG Capital Management (Massachusetts) Portfolio holdings

AUM $102M
1-Year Est. Return 29.14%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+29.14%
3 Year Est. Return
+96.74%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$166M
AUM Growth
-$109K
Cap. Flow
-$7.01M
Cap. Flow %
-4.23%
Top 10 Hldgs %
29.78%
Holding
76
New
12
Increased
23
Reduced
29
Closed
11

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.02M
2
CSIQ icon
Canadian Solar
CSIQ
+$2.54M
3
ULTA icon
Ulta Beauty
ULTA
+$2.21M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.6M
5
ABBV icon
AbbVie
ABBV
+$1.46M

Top Sells

Rank Stock Value
1
CB icon
Chubb
CB
+$2.79M
2
TXN icon
Texas Instruments
TXN
+$2.45M
3
AMGN icon
Amgen
AMGN
+$2.42M
4
HAR
Harman International Industries
HAR
+$2.32M
5
TSN icon
Tyson Foods
TSN
+$1.89M

Sector Composition

Rank Sector Weight
1 Healthcare 39.3%
2 Financials 15.77%
3 Technology 11.18%
4 Communication Services 8.59%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNKD
76
DELISTED
LinkedIn Corporation
LNKD
– –
-5,225
Closed -$1.31M
1 2 3
4

Similar funds

LOT
Lombard Odier Transatlantic Montreal, Quebec, Canada $105M AUM 13.73% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
PCM
Panning Capital Management New York $97.5M AUM 302.5% 1-Year Est. Return
EDRAML
Edmond de Rothschild Asset Management (Luxembourg) Luxembourg $95.2M AUM 19.45% 1-Year Est. Return
EC
Eachwin Capital New York $108M AUM 14.45% 1-Year Est. Return
SAMNY
Samsung Asset Management (New York) New York $109M AUM 14.33% 1-Year Est. Return
BCCM
Blue Clay Capital Management Minneapolis, Minnesota $88.7M AUM 6.88% 1-Year Est. Return
EIAM
Equinox Institutional Asset Management Princeton, New Jersey $87.9M AUM 1.01% 1-Year Est. Return

DG Capital Management (Massachusetts)'s Q2 2015 Portfolio in Review

As of Q2 2015, DG Capital Management (Massachusetts) held 76 positions worth $166M, down 0.07% from $166M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

DG Capital Management (Massachusetts) withdrew a net $7.01M in Q2 2015, closing 11 positions and reducing 29 holdings. Its most notable exit was Chubb, an estimated $2.79M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 37% a quarter earlier, followed by Financials and Technology.

Against the trend, DG Capital Management (Massachusetts) opened a new position in BioMarin Pharmaceuticals worth $3.33M.

  • DG Capital Management (Massachusetts)'s largest Q2 2015 buy was BioMarin Pharmaceuticals: 24,345 shares worth $3.33M.
  • DG Capital Management (Massachusetts) added most to Bristol-Myers Squibb in Q2 2015, an estimated $1.6M increase.
  • DG Capital Management (Massachusetts)'s biggest Q2 2015 reduction was Amgen, cutting an estimated $2.42M.
  • DG Capital Management (Massachusetts) fully exited Chubb in Q2 2015, selling an estimated $2.79M.
  • DG Capital Management (Massachusetts)'s ten largest holdings make up 30% of its $166M portfolio in Q2 2015.
  • DG Capital Management (Massachusetts) opened 12 new positions and closed 11 in Q2 2015.
  • DG Capital Management (Massachusetts)'s portfolio value fell 0.07% quarter-over-quarter to $166M.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q2 2015, filed 11 Aug 2015.